entertainment -WSS

entertainment

author：focus 2025-09-27 12:56:46 - browse：7

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Device maker Teleflex to acquire urology company for $600M

WSS

What to watch for from Zogenix and Amicus clinical trials

Device maker Teleflex to acquire urology company for $600M

CommonSpirit Health keeps growing, even as it loses money

What causes rare myocarditis in young men after Covid vaccines?

STAT Virtual Event: Putting AI to the Test

In the gardens at Boston Children's Hospital, families find sanctuary

entertainment

entertainment

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Second xenotransplant done with gene

How one medical school became remarkably diverse

Search called off for baby washed away in Pennsylvania flash flood

BioMarin wins approval for gene therapy to treat hemophilia A

What Congress can do to address the rural doctor shortage

BioMarin wins approval for gene therapy to treat hemophilia A

Dems pitch expanding Medicare power to negotiate drug prices

New air purifier tech could be key to improving indoor air quality

Changes to biosimilar regulatory framework must prioritize patients

knowledge

Democrats decry new health bill for going easy on private equity

UHS says company favors patients whose insurance pays more

Thermo Fisher plant for manufacturing gene therapies to expand

Former reverend arrested for allegedly killing 8

EpiPen alternative approval delay highlights citizen petition issue

In the gardens at Boston Children's Hospital, families find sanctuary

knowledge

focus

leisure time

leisure time